Novel dose escalation to predict treatment with hydroxyurea (NDEPTH): A randomized controlled trial of a dose-prediction equation to determine maximum tolerated dose of hydroxyurea in pediatric sickle cell disease

Am J Hematol. 2020 Sep;95(9):E242-E244. doi: 10.1002/ajh.25883. Epub 2020 Jul 4.

¹ Department of Pediatrics, Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, Texas, USA.
² Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.
³ Division of Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
⁴ University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

No abstract available

Publication types